The economic and health recovery of countries in the Asia-Pacific region from the pandemic is hinged on the rapid and equitable deployment of safe and effective COVID-19 vaccines. However, in the initial years of the COVID-19 vaccine roll-out, highly unequal distribution of vaccines occurred...

The COVID-19 pandemic has highlighted both the strengths and weaknesses of national, regional, and global vaccine research and development (R&D) systems. Translating public and private R&D efforts into effective vaccines in a timely manner requires not only sufficient financial and scientific...

The COVID-19 pandemic re-emphasized the role of vaccines in prevention and control of outbreaks and infectious diseases, but not all countries are able to produce them. Limited domestic capacities combined with other bottlenecks have often resulted in vaccine stockouts in many countries. In this...

For decades, East and Southeast Asia have experienced repeated threats from outbreaks of emerging infectious diseases that have contributed to widespread human suffering and death at the global level. The SARS epidemic and highly pathogenic H5N1 avian influenza provide just two recent examples...